Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale

December 19, 2023

https://www.prnewswire.com/news-releases/impel-pharmaceuticals-announces-filing-of-voluntary-chapter-11-cases-and-signing-of-stalking-horse-agreement-to-facilitate-sale-302019714.html

Patient Access to Trudhesa® to Continue Uninterrupted

Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process

SEATTLE, Dec. 19, 2023 /PRNewswire/ — Impel Pharmaceuticals Inc. (OTCQX: IMPL) (“Impel” or “the Company”), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it is pursuing a sale of the Company and has entered into an agreement with JN BIDCO LLC to serve as the “stalking horse” bidder to acquire the Company and its assets.

Read more at prnewswire.com

Related news for (IMPL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.